Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_3
2
67%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Other(3)

Detailed Status

unknown3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 32 (66.7%)
N/A1 (33.3%)

Trials by Status

unknown3100%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_3

Supreme-LMA for Neonatal Resuscitation: a Prospective, Randomized Single-center Study

NCT01963936
unknownnot_applicable

Supreme LMA and Proseal LMA in Prone Anesthetized Patient

NCT01814306
unknownphase_3

Laryngeal Masks for Bariatric Surgery

NCT01724970

Clinical Trials (3)

Showing 3 of 3 trials
NCT01963936Phase 3

Supreme-LMA for Neonatal Resuscitation: a Prospective, Randomized Single-center Study

Unknown
NCT01814306Not Applicable

Supreme LMA and Proseal LMA in Prone Anesthetized Patient

Unknown
NCT01724970Phase 3

Laryngeal Masks for Bariatric Surgery

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3